Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): Protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score

Vietnam and Saudi Arabia have high disease burden of primary hepatocellular carcinoma (HCC). Early detection in asymptomatic patients at risk for HCC is a strategy to improve survival outcomes in HCC management. GALAD score, a serum-based panel, has demonstrated promising clinical utility in HCC management.